Decitabine With Venetoclax vs Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ten-Day Decitabine With Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score-Matched Analysis
Cancer 2021 Aug 03;[EPub Ahead of Print], A Maiti, CD DiNardo, W Qiao, TM Kadia, EJ Jabbour, CR Rausch, NG Daver, NJ Short, G Borthakur, N Pemmaraju, M Yilmaz, Y Alvarado, KS Montalbano, A Wade, RE Maduike, JA Guerrero, K Vaughan, CA Bivins, S Pierce, J Ning, F Ravandi, HM Kantarjian, MY KonoplevaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.